FDA Approves Moderna's First mRNA Flu Vaccine for Seniors

FDA approved Moderna's mFlusiva, the first U.S. mRNA flu vaccine, for adults 50+. It reduces flu cases by 27% compared to traditional shots and cuts manufacturing timelines down to two to three months.